Stock comparison
Galapagos N.V.
Harmony Biosciences Holdings
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GLPG
Galapagos N.V.
Market cap
$1.81B
Sector
Healthcare
HRMY
Harmony Biosciences Holdings
Market cap
$1.75B
Sector
Healthcare
Overall winner
Harmony Biosciences Holdings HRMY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GLPG | HRMY | Winner |
|---|---|---|---|
| Warren Buffett | 41D | 67B | HRMY |
| Benjamin Graham | 28F | 60C | HRMY |
| Philip Fisher | 56C | 75B | HRMY |
| Peter Lynch | 76B | 62C | GLPG |
| Joel Greenblatt | 39D | 28F | GLPG |
| Charlie Munger | 46D | 62C | HRMY |
| Terry Smith | 46D | 67B | HRMY |
Side-by-side metrics
| Metric | GLPG | HRMY |
|---|---|---|
| Market cap | $1.81B | $1.75B |
| P/E (TTM) | 3.1x | 11.8x |
| EV/EBIT | 2.9x | 6.4x |
| ROIC (TTM) | 17.67% | 12.5% |
| Gross margin | 98.01% | 76.55% |
| Net margin | 46.83% | 16.2% |
| Revenue CAGR 5y | 23.07% | 29.85% |
| EPS CAGR 5y | - | 46.45% |
| Debt / Equity | 0.0x | 0.2x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GLPG leads on
- Debt / Equity0.0xvs 0.2x+99%
- P/E (TTM)3.1xvs 11.8x+74%
- Net margin46.83%vs 16.2%+65%
- EV/EBIT2.9xvs 6.4x+55%
HRMY leads on
- Revenue CAGR 5y29.85%vs 23.07%+23%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.